目的 分析民用机场应急救护能力并提出对策.方法 采用发放调查问卷和现场访谈的形式,选取国内某地区24个民用机场的应急救护人员共240人,对应急救护能力、知识和培训需求等问题进行调查,比较分析现存问题的原因并提出策略建议.结果 应急救护人员对各维度的掌握情况具有显著差异性,不同岗位人员的掌握情况也存在差异;普遍认为培训不系统不科学.结论 应更有针对性地进行机场应急救护能力培训,同时提升培训和演练的投入水平.

目的:研究诊疗质量控制全流程精细化管理对急性缺血性脑卒中(AIS)患者预后及满意度的影响.方法:选取院收治的500例AIS患者,按照管理方式的不同将其分为对照组(256例)和观察组(244例),所有患者均采用静脉溶栓治疗,对照组按临床指南组织化管理,观察组按诊疗质量控制全流程精细化管理.比较两组患者静脉溶栓疗效、溶栓流程各环节时长、患者临床预后以及患者满意度和投诉率的差异.结果:观察组患者静脉溶栓疗效明显好于对照组,差异有统计学意义(x2=14.96,P<0.05);观察组患者发病至静脉溶栓4个环节时长少于对照组,差异有统计学意义(t=12.456,t=23.015,t=26.356,t=1.896;P<0.05);观察组患者出院后6个月临床预后数据优于对照组,差异有统计学意义(x2=9.99;P<0.05);观察组患者满意情况好于对照组,投诉率低于对照组,差异有统计学意义(x2=33.58,x2=8.03;P<0.05).结论:诊疗质量控制全流程精细化管理可显著降低患者发病到溶栓时间,改善临床预后,提升AIS患者满意度.

In recent years, public emergencies, especially public health emergencies, have occurred frequently. In the process of emergency rescue, there is often a shortage of emergency medical supplies. Public donation is one of the effective ways to alleviate the shortage of emergency medical supplies. In this paper, the authors analyzed the problems of public hospitals accepting social donations in public health emergencies, discussed the legal risks, and put forward countermeasures and suggestions for relevant departments.

新型冠状病毒肺炎(COVID-19)的爆发与流行严重威胁人民生命安全,疫情后的防控工作任务重大.医院是COVID-19发生和聚集性感染的高危场所,故应实行预检分诊制度,采用加强入院筛查管理,启动隔离手术间,设置急诊入院过渡病房等措施,确保做好疫情防控的同时,保障人民群众日常医疗服务需求,对全面助力打赢疫情防控阻击战具有重要意义.

The General Rules of the Civil Law of the People′s Republic of China(hereinafter the General Rules)shall officially come into effect as of July 1 of 2017.In this consideration,the paper probed into the legal attributes of the doctor-patient relationship in China in view of the relationship management in line with the General Rules.Also analyzed are the basic principles to be observed by both parties as regulated by the General Rules and patient rights protection.These efforts aim at elevating China′s medical service,protecting legitimate rights of both parties,and encourage a healthy and harmonious doctor-patient relationship.

Legitimate clinical trials of drugs may cause injuries for participants as well.It is inevitable for drug sponsors and researchers to bear some particular tort liabilities when medical injuries occur.The PRC Tort Liability Law outlines in its fifth chapter the product liability,and prescribes in its seventh chapters the tort liability for medical injury compensation including product liability,but it does not specify the nature of the tort liability for clinical trial of drugs.The author of this paper argues that the legal nature for drug clinical trial is different from that of clinical treatment although both have patients as the object of their study or treatment.Legal liabilities should differ for different parties involved in drug clinical trials due to their different status.Drug sponsors should be subject to product liability while researchers are subject to medical injury liability.Only this can maximize the protection of the interests of the participants in the drug clinical trial.

The doctor-patient relationship management has become an indispensable contents of hospital management,many in the medical institutions set up a full-time doctor-patient relationship management department,training,exercise a batch of professional management staff,to set up and promote harmonious doctor-patient relationship important strength.The author according to their work experience,this paper discusses the doctor-patient relationship management department full-time the necessity of,the main content,principle and position,need to coordinate the various relations,the doctor-patient relationship management personnel of full-time the quality and ability of requirements,and other related issues.

Tort liability law of the People's Republic of China has effected since July 1,2010,medical disputes handling is occurring many changes.The types of medical disputes are not changed,but medical liability is classified into special tort liability for the first time,which means the responsibility and liability of medical dispute has mainly belonged to fault liability principle,Thus brings great changes for evidential burden.But in some special situations still requires health institutes presuming fault liability,some of the evidential burden is still required by the medical institutes.Based on the evidential burden,the type,institutes,rationale,suing and fee of medical fault identification have also changed.As a staff of patient hospital relationship office in a tertiary hospital,through the work of the intimate understanding,the main changes of medical dispute handling before and after implementation of the tort liability law is analyzed and suggestions on how to aware this change and how to deal with it is also discussed.